In Africa, pregnant women and young children are the most vulnerable to malaria.
However, malaria control interventions and strategies have achivied important results in the last years.
COVID-19 has now made these interventions critical, and could undo the results obtained so far, as highlighted by scientists in the Lancet: https://bit.ly/2Tfyxwn.
Potentially, COVID-19 could indirectly cause more deaths than it already does directly, in the context of Africa’s weak and fragile health systems.
A European-African partnership aimed at improving the ethics and regulatory capacity of clinical research in Central African countries has successfully proposed its project (AfriHetique) to the European Commission (EDCTP). The partnership
The symposium, organised by The Embassy of Good Science, in collaboration with EUREC, BERC-Luso, AfriEthique, and LiberHetica, aims to facilitate the sharing of experiences and perspectives on research ethics assessment challenges between African and
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including